A new study by researchers at the Walter and Eliza Hall Institute in Melbourne, Australia, has shown that mature blood cells can communicate with, and influence the behaviour of, their stem cell 'parents'.
The discovery of a blood cell 'feedback loop' in the body opens up new avenues of research into diseases caused by stem cell disorders, and the potential for new disease treatments.
Dr Carolyn de Graaf and Professor Doug Hilton from the Molecular Medicine division and Professor Warren Alexander from the Cancer and Haematology division led the research.
Professor Hilton said the findings, published November 29 in the Proceedings of the National Academy of Sciences, revealed a relationship between the blood cells that wasn't known to exist until now.
"We know that blood stem cells give rise to all the mature blood cells, but the standard assumption was that external factors control blood cell production and the two populations exist in isolation," Professor Hilton said.
"This study shows that the mature cells actually communicate back to the stem cells, changing their gene expression and influencing their behaviour."
The researchers found that blood cell disorders can cause disturbances in the feedback loop, with profound effects on the blood stem cells.
The discovery was made while studying the effect of the loss of Myb, a transcription factor that represses platelet production, in animal models.
Dr de Graaf said the loss of the Myb gene meant the animals had very high numbers of platelets in their blood, which caused changes in the signaling pathways that control stem cell maintenance.
"The stem cells, rather than being maintained in a 'resting state' until needed, were being told to continually cycle and produce mature blood cells," Dr de Graaf said. "The stem cells were eventually exhausted and blood disorders developed because there were not enough stem cells to produce new red and white blood cells."
The team used new generation genomic technologies to identify gene signatures in the blood stem cells that were caused by the defective signaling, these gene signatures could be used in the future to diagnose and help treat disease.
"If we can understand the genes important for stem cell maintenance and blood cell production, then we can start to look at ways of improving transplantation techniques and therapies for blood disorders," Dr de Graaf said.
Professor Hilton said that patients with stem cell failures could also potentially benefit.
"What we would like to do is to determine whether some of these stem cell failures are due to miscommunication between mature blood cells and stem cells, with the possibility of finding new ways to treat these disorders down the track," he said.
This study was supported by the National Health and Medical Research Council, the National Heart, Lung, and Blood Institute, the Cancer Council Victoria, the Australian Cancer Research Foundation, Murigen Pty Ltd and the Australian Stem Cell Centre.
Cite This Page: